“And what will poor robin do then, poor thing?” RED ROBIN GOURMET BURGER [RRGB] flew south dropping 26.1% to close at $34.00 after announcing weak third quarter results, revising guidance downward, and then getting hammered by five separate downgrades. The company reported third quarter earnings of $0.36 per share ($0.42 excluding special charges), compared with $0.39 per share for the same period last year. The consensus estimate had been for earnings of $0.43 per share. Revenue for the quarter was $148.6 million, compared with $114.2 million for the same period last year. Basically the income statement for the third quarter wasn’t all that bad. However, the company now projects full-year earnings to be in the range of $1.62 to $1.67 per share on revenue of between $611 and $613 million, down from previous guidance in the range of $1.74 to $1.83 per share and previous revenue guidance in the range of $615 to $618 million. Perhaps this would have justified about an 8% drop in price. But additional pressure came from the analysts. CIBC World Markets downgraded RRGB from “Sector Outperform” to “Sector Perform,” Friedman Billings from “Outperform” to “Market Perform,” Bear Stearns from “Outperform” to “Peer Perform,” Banc of America Securities from “Buy” to “Neutral” and McAdams Wright Ragen from “Buy” to “Hold.” With 30% revenue growth, I would normally be inclined to judge this as a buying opportunity. However, there is one other area of concern. The balance sheet has an awful current ratio - current assets/current liabilities = .32 - compared with a ratio of about 2 that is much more typical. Of particular concern is the “construction related payables” line item of about $21 million under current liabilities with only $4.2 million in cash and cash equivalents. Looks like long-term debt can be expected to balloon even more in the next couple of quarters.
NEUROCRINE BIOSCIENCES [NBIX] fell off another cliff, dropping 30% to close at $7.72, a far cry from its high of $72.14 on the Ides of March. The drop can be attributed to both third quarter financials and an update on the status of the indiplon (the new insomnia drug being developed by the company). While the company had received conditional approval for the 5 and 10 mg capsules back in May, the FDA rejected the application for the extended-release tablets, which analysts felt had greater sales potential. (Personally, I think it has more to do with what the doctor prescribes than the analyst’s belief that the extended-release tablets are more attractive for some reason.) Basically, the FDA wants more long-term safety and effectiveness studies for the 15 mg extended-release tablets. The NDA for the indiplon capsules for the treatment of insomnia, which will include additional clinical studies on safety and efficacy, is currently targeted to be resubmitted in the summer of 2008! The company is in the process of “formulating a strategy to pursue a sleep maintenance claim for indiplon.” The FDA also wants a separate dose for the elderly population. Before we dose off here, let’s take a quick look at the third quarter numbers (which might induce a case of pavor nocturnus). The company reported a net loss of $39.1 million or $1.03 per share compared to a net income of $26.2 million or $0.71 per share for the same period in 2005. Revenues for the third quarter were $1.1 million compared with $64.7 million for the same period last year. The company expects the net cash burn for 2006 will be about $100 million and expects to end the year with about $180 million in cash, cash equivalents and marketable securities. It is projecting the net cash burn in 2007 to be approximately $80 million. Looking at the pipeline, the only fourth quarter expectations seem to involve some early Phase 2 clinical studies, with no significant revenue generators in the next couple of years. Survival is probably going to require a more “well-controlled burn rate” or external funding strategies. Avoid the falling knife.
WHOLE FOODS MARKET INC [WFMI] was crushed 23.1% closing at $46.26 after announcing fourth quarter results that basically met expectations, but revising downward its guidance for 2007. The company reported fourth quarter earnings of $0.28 per share, compared with the consensus estimate of $0.29 per share on revenue of $1.3 billion, up 16% over the same period last year. Comparable store sales increased 8.6% for the quarter. The company is now projecting growth the growth rate for fiscal year 2007 will be in the range of 13% to 17%. Not helping matters was a downgrade by Banc of America Securities from “Buy” to “Neutral.” The company also increased its quarterly dividend payment to $0.18 per share. At this point, we see nothing in the news events that would justify the magnitude of the drop and would have to conclude that this is a buying opportunity.
AQUANTIVE INC [AQNT], an online advertising agency, was down 20.8% closing at $22.73 after announcing third quarter results and revealing turnover issues. The company reported that third quarter revenue was $111 million, up 41% over the third quarter 2005. Net income for the quarter was $13.6 million or $0.16 per diluted share. The consensus estimate for revenue had been $119.15 million and the shortfall was attributed to both a delay in a web project that resulted in the delivery date slipping into the fourth quarter, and some unexpected turnover in the sales force in May. One estimate is that AQNT lost about 5 sales people making up roughly half of its sales force. Downgrades by Merriman Curhan Ford from “Buy” to “Neutral” and by RBC Capital Markets from “Outperform” to “Sector Perform” undoubtedly magnified the hit. Our sense is that the magnitude of the drop is not justified at this time but that the P/E ratio is too high, even given the growth in the online advertising world.
SIX FLAGS INC [SIX] surged 11.2% closing at $6.24 after announcing a strong third quarter. The company reported earnings of $159.3 million or $1.08 per diluted share, compared to $190.2 million or $1.29 per diluted share for the same period last year. Total revenue for the quarter was $540.7 million down 1% from the same period last year, reflecting a decline in attendance that was not quite offset by a rise in revenue per guest. The decline in attendance (12%) was attributed to weather, but presumably also had something to do with the previously indicated increase in ticket prices and higher gasoline prices. The focus on “initiatives designed to foster a family-friendly environment and a more diversified entertainment offering” appear to be bearing fruit in stabilizing attendance during the quarter, but we will have to wait for fourth quarter numbers to be sure. In any case, it is clear that the new initiatives are costing more money. Adjusted EBITDA for the quarter, which excludes the operations of parks planned for closure, was down 7% compared to the same period last year, which does not sound encouraging. On balance, we would like to see one more quarter of results before agreeing that a turnaround is underway.
ELECTRONIC ARTS INC [ERTS] scored big, up 11.8% to close at $59.24 after announcing better than expected second quarter financials. The company announced earnings of $22 million on a GAAP basis, and $65 million or $0.21 per diluted share, on a non-GAAP basis, compared with $0.15 per diluted share for the same period last year, easily topping the consensus estimate of $0.02 per diluted share. Perhaps even more important, the company revised its guidance for the current quarter up slightly, looking for about the same level of sales as last year instead of a 5% drop indicated earlier. Given the record success of Madden NFL 07 and NCAA Football 07, and the NHL® trajectory, it would be hard to miss the lay-up here.
JDS UNIPHASE CORP [JDSUD] jumped up 16.1% closing at $16.58 following the announcement of financial results for the first quarter of fiscal 2007. The company reported a GAAP net loss of $0.22 per share and non-GAAP profit of $0.03 per share, compared to a net loss of $0.34 for the same period last year. The consensus estimate had been for a profit of $0.01 per share (non-GAAP). The stock was upgraded by Deutsche Bank from “Hold” to “Buy” and by Needham & Co. from “Buy” to “Strong Buy.” However, first quarter revenues of $318.1 million falling below the consensus estimate of $322 million. For the second quarter of fiscal 2007, ending December 31st, the company projects revenues will be in the range of $332 to $352 million, which is in line with the current consensus estimate. Not seeing much more upside potential here.
STELLENT INC [STEL], a global provider of Enterprise Content Management (ECM) software, surged 26.2% to close at $13.40 on the news of yet another ORACLE CORP [ORCL] buyout. The voracious appetite of this orca for enterprise software companies continues to amaze. Given the healthy premiums being paid and concerns about the challenges of assimilating so many different cultures in such a short period of time, some caution should be taken with ORCL. The $74 million in goodwill from STELLENT raised my eyebrows, but when you’ve already got $7 billion in goodwill on the books, what’s another $74 million?
The Daily Sector Performance Chart
Somewhat surprisingly, given the drops in some of the major indices, the average gain in the SigmaInverse Universe on Friday was 0.33% with 53.9% of the members posting positive returns for the day.
The big gainers for the day were Oil & Gas Production (up 2.6%) and Scientific & Technology Instruments (up 1.7%). The big loser was Restaurants (down 1.8%).
